These 2 Stocks Are Trading at a Once-in-a-Lifetime Price
The coronavirus has been bad news for U.S. stock prices. The Dow Jones Industrial Average has given back most of its gains during the Donald Trump presidency, and scores of blue-chip equities are now trading at multiyear lows as a result. Despite this historic marketwide drop in stock prices, however, most equities still aren't worth buying right now. The unfortunate truth is that the pandemic is probably several weeks away from hitting a peak in the United States, making it virtually impossible to open up the broader economy. So with little to no economic activity on the near-term horizon, stock prices are bound to print lower lows as this public health crisis deepens during the month of April.
But there are a few bright spots in this dour market. Companies that produce products essential to daily life, such as medical devices and pharmaceuticals, should eventually separate themselves from the pack. Keeping with this theme, the diabetes medical device specialist DexCom (NASDAQ: DXCM) and the pharmaceutical titan Pfizer (NYSE: PFE) are both trading at once-in-a-lifetime prices right now. Here's why investors may want to add these two top healthcare stocks to their portfolios soon.
Image source: Getty Images.
Source Fool.com